- Home
- TCRT vs PRSO Comparison
TCRT vs PRSO Comparison
Compare TCRT & PRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRT
- PRSO
- Stock Information
- Founded
- TCRT 1998
- PRSO 2008
- Country
- TCRT United States
- PRSO United States
- Employees
- TCRT N/A
- PRSO N/A
- Industry
- TCRT Biotechnology: Pharmaceutical Preparations
- PRSO Semiconductors
- Sector
- TCRT Health Care
- PRSO Technology
- Exchange
- TCRT Nasdaq
- PRSO Nasdaq
- Market Cap
- TCRT 3.8M
- PRSO 4.2M
- IPO Year
- TCRT N/A
- PRSO 2001
- Fundamental
- Price
- TCRT $1.99
- PRSO $1.04
- Analyst Decision
- TCRT
- PRSO Strong Buy
- Analyst Count
- TCRT 0
- PRSO 2
- Target Price
- TCRT N/A
- PRSO $3.38
- AVG Volume (30 Days)
- TCRT 33.0K
- PRSO 125.2K
- Earning Date
- TCRT 11-14-2024
- PRSO 11-12-2024
- Dividend Yield
- TCRT N/A
- PRSO N/A
- EPS Growth
- TCRT N/A
- PRSO N/A
- EPS
- TCRT N/A
- PRSO N/A
- Revenue
- TCRT $7,000.00
- PRSO $12,728,000.00
- Revenue This Year
- TCRT N/A
- PRSO $9.59
- Revenue Next Year
- TCRT N/A
- PRSO $1.63
- P/E Ratio
- TCRT N/A
- PRSO N/A
- Revenue Growth
- TCRT N/A
- PRSO N/A
- 52 Week Low
- TCRT $1.63
- PRSO $0.73
- 52 Week High
- TCRT $33.00
- PRSO $11.20
- Technical
- Relative Strength Index (RSI)
- TCRT 43.99
- PRSO 55.90
- Support Level
- TCRT $1.63
- PRSO $0.80
- Resistance Level
- TCRT $2.10
- PRSO $1.12
- Average True Range (ATR)
- TCRT 0.30
- PRSO 0.09
- MACD
- TCRT -0.04
- PRSO 0.05
- Stochastic Oscillator
- TCRT 21.03
- PRSO 88.69
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations.
About PRSO Peraso Inc.
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.